Whalegun
List

Guidance and Procedures for Implementing Tariff Adjustments for Specialty Pharmaceuticals and Associated Pharmaceutical Ingredients and Technical Corrections to the Harmonized Tariff Schedule of the United States for Duties Imposed Under Proclamation 11020

BIS ruleTariff cut or exemptionFederal Register 09/23Open the original

Summary

The Bureau of Industry and Security sets the eligible products and procedures for a zero tariff rate on specialty pharmaceuticals and associated ingredients. Information requests are received starting September 23, 2026, and certain products receive a zero rate under section 232.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/09/220.0%0.0%
26/09/23−0.9%−0.7%
26/09/24−0.8%−0.8%
26/09/25−0.1%−0.2%
26/09/28−0.0%−1.0%
26/09/29−0.1%−1.0%
26/09/30−1.3%−1.1%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030
  • Hyundai Steel 004020
  • POSCO Holdings 005490
  • SeAH Steel Holdings 003030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Kevin Hern

    Full saleUnitedhealth Group

    $15K–$50K

    Reported 09/25

  • Pete Sessions

    Full saleAbbVie

    $15K–$50K

    Reported 09/18

  • Thomas H. Kean Jr.

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/12

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • Timothy J. Harris

    Sell10b5-1 planAti

    $1.7M

    Filed 09/23